Retatrutide


product specifications:


5mg*10vials      10mg*10vials


15mg*10vials     20mg*10vials


30mg*10vials     40mg*10vials


50mg*10vials     60mg*10vials




Description

Basic Info.

Retatrutide is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist.

In a phase II clinical trial, the drug has been proved to reduce the average weight of non diabetes but obese or pre obese (overweight) adults by more than 17.5%


packing & Delivery

Product packaging

We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.

Send A Message

We'd love to hear from you if you have any questions!

RTL Version
  • RTL Version
  • LTR Version